9 Comments

Very difficult to place a value on this kind of company, but you have done a really good job of it. Too many assumptions need to be made, which is why buying it cheap is the only thing that can really help. Price to sales right now is still very high.

Do you have an idea of what proportion of management wealth is invested. I know you said 10% through Equilibrium...but what % of this is their total wealth?

Expand full comment
author

Apologies for the late response. I am confident this is a large, if not the largest component of their net worth based on my conversations with people who are very familiar with the company. Haven't spoken with Sverre or Einar, so have not been able to confirm for myself.

Expand full comment

I really appreciate your analysis. This stock is hard to evaluate. For me too risky. Would you like to cover in the coming weeks Lifco, Addtech, Judges Scientific and Lgercrantz?

Expand full comment
author

Will probably not cover them for a while. I prefer to focus on other types of companies for the time being.

Expand full comment

Which ones? Healthcare?

Expand full comment
author

Starting with Medistim. Should be posted earlier than the usual month.

Expand full comment
Aug 20, 2022·edited Aug 20, 2022

haha guess what is open in my screener at the moment :D Nice one. Looking forward reading. I just miss the growth here. 10% is not that what I am looking for.

Expand full comment

thanks! any clue how it compares to the swiss stock Ascom? who would take over who between the two?

Expand full comment
author

Don't know anything about Ascom, I'm sorry.

Expand full comment